|
1.
|
Regezi JA, Sciubba JJ and Jordan RCK: Oral
Pathology: Clinical Pathologic Correlations. 5th edition.
Saunders-Elsevier; Philadelphia, PA: pp. 552–556. 2008
|
|
2.
|
Ariyoshi Y, Shimahara M, Omura K, Yamamoto
E, Mizuki H, Chiba H, Imai Y, Fujita S, Shinohara M and Seto K;
Japanese Society of Oral and Maxillofacial Surgeons:
Epidemiological study of malignant tumors in the oral and
maxillofacial region: survey of member institutions of the Japanese
Society of Oral and Maxillofacial Surgeons, 2002. Int J Clin Oncol.
13:220–228. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Choi S and Myers JN: Molecular
pathogenesis of oral squamous cell carcinoma: implications for
therapy. J Dent Res. 87:14–32. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View
Article : Google Scholar
|
|
6.
|
Fuchs E: Epidermal differentiation: the
bare essentials. J Cell Biol. 111:2807–2814. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Ward PS and Thompson CB: Metabolic
reprogramming: a cancer hallmark even Warburg did not anticipate.
Cancer Cell. 21:297–308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Furuhashi M and Hotamisligil GS: Fatty
acid-binding proteins: role in metabolic diseases and potential as
drug targets. Nat Rev Drug Discov. 7:489–503. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Smathers RL and Petersen DR: The human
fatty-acid binding protein family: evolutionary divergences and
functions. Hum Genomics. 5:170–191. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Siegenthaler G, Hotz R, Chatellard-Gruaz
D, Jaconi S and Saurat JH: Characterization and expression of a
novel human fatty acid-binding protein: the epidermal type
(E-FABP). Biochem Biophys Res Commun. 190:482–487. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Fang LY, Wong TY, Chiang WF and Chen YL:
Fatty-acid-binding protein 5 promotes cell proliferation and
invasion in oral squamous cell carcinoma. J Oral Pathol Med.
39:342–348. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Melle C, Ernst G, Winkler R, Schimmel B,
Klussmann JP, Wittekindt C, Guntinas-Lichius O and von Eggeling F:
Proteomic analysis of human papillomavirus-related oral squamous
cell carcinoma: identification of thioredoxin and epidermal-fatty
acid binding protein as upregulated protein markers in
microdissected tumor tissue. Proteomics. 9:2193–2201. 2009.
View Article : Google Scholar
|
|
13.
|
Uma RS, Naresh KN, D’Cruz AK, Mulherkar R
and Borges AM: Metastasis of squamous cell carcinoma of the oral
tongue is associated with down-regulation of epidermal fatty acid
binding protein (E-FABP). Oral Oncol. 43:27–32. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Hashimoto T, Kusakabe T, Sugino T, Fukuda
T, Watanabe K, Sato Y, Nashimoto A, Honma K, Kimura H, Fujii H and
Suzuki T: Expression of heart-type fatty acid-binding protein in
human gastric carcinoma and its association with tumor
aggressiveness, metastasis and poor prognosis. Pathobiology.
71:267–273. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Nieman KM, Kenny HA, Penicka CV, Ladanyi
A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Millis GB,
Hotamisligil GS, et al: Adipocytes promote ovarian cancer
metastasis and provide energy for rapid tumor growth. Nat Med.
17:1498–1503. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Celis JE, Ostergaard M, Basse B, Celis A,
Lauridsen JB, Ratz GP, Andersen I, Hein B, Wolf H, Orntoft TF and
Rasmussen HH: Loss of adipocyte-type fatty acid binding protein and
other protein biomarkers is associated with progression of human
bladder transitional cell carcinomas. Cancer Res. 56:4782–4790.
1996.
|
|
17.
|
Boiteux G, Lascombe I, Roche E,
Plissonnier ML, Clairotte A, Bittard H and Fauconnet S: A-FABP, a
candidate progression marker of human transitional cell carcinoma
of the bladder, is differentially regulated by PPAR in urothelial
cancer cells. Int J Cancer. 124:1820–1828. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Hammamieh R, Chakraborty N, Barmada M, Das
R and Jett M: Expression patterns of fatty acid binding proteins in
breast cancer cells. J Exp Ther Oncol. 5:133–143. 2005.PubMed/NCBI
|
|
19.
|
Okuse T, Chiba T, Katsuumi I and Imai K:
Differential expression and localization of WNTs in an animal model
of skin wound healing. Wound Repair Regen. 13:491–497. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
McCluggage WG, Connolly LE, McBride HA,
Kalloger S and Gilks CB: HMGA2 is commonly expressed in uterine
serous carcinomas and is a useful adjunct to diagnosis.
Histopathology. 60:547–553. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Masouye I, Hagens G, Van Kuppevelt TH,
Madsen P, Saurat JH, Veerkamp JH, Pepper MS and Siegenthaler G:
Endothelial cells of the human microvasculature express epidermal
fatty acid-binding protein. Circ Res. 81:297–303. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kusakari Y, Ogawa E, Owada Y, Kitanaka N,
Watanabe H, Kimura M, Tagami H, Kondo H, Aiba S and Okuyama R:
Decreased keratinocyte motility in skin wound on mice lacking the
epidermal fatty acid binding protein gene. Mol Cell Biochem.
284:183–188. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Han J, Kioi M, Chu WS, Kasperbauer JL,
Strome SE and Puri RK: Identification of potential therapeutic
targets in human head and neck squamous cell carcinoma. Head Neck
Oncol. 1:272009. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Chi C and Trinkaus-Randall V: New insights
in wound response and repair of epithelium. J Cell Physiol.
228:925–929. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Martin P: Wound healing - aiming for
perfect skin regeneration. Science. 276:75–81. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Singer AJ and Clark RA: Cutaneous wound
healing. N Engl J Med. 341:738–746. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Ogawa E, Owada Y, Ikawa S, Adachi Y, Egawa
T, Nemoto K, Suzuki K, Hishinuma T, Kawashima H, Kondo H, et al:
Epidermal FABP (FABP5) regulates keratinocyte differentiation by
13(S)-HODE-mediated activation of the NF-κB signaling pathway. J
Invest Dermatol. 131:604–612. 2011.PubMed/NCBI
|
|
28.
|
Hagens G, Masouye I, Augsburger E, Hotz R,
Saurat JH and Siegenthaler G: Calcium-binding protein S100A7 and
epidermal-type fatty acid-binding protein are associated in the
cytosol of human keratinocytes. Biochem J. 339:419–427. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Dallaglio K, Marconi A, Truzzi F, Lotti R,
Palazzo E, Petrachi T, Saltari A, Coppini M and Pincelli C: E-FABP
induces differentiation in normal human keratinocytes and modulates
the differentiation process in psoriatic keratinocytes in vitro.
Exp Dermatol. 22:255–261. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Gandarillas A: The mysterious human
epidermal cell cycle, or an oncogene-induced differentiation
checkpoint. Cell Cycle. 11:4507–4516. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Ashida S, Orloff MS, Bebek G, Zhang L,
Zheng P, Peehl CM and Eng C: Integrated analysis reveals critical
genomic regions in prostate tumor microenvironment associated with
clinicopathologic phenotypes. Clin Cancer Res. 18:1578–1587. 2012.
View Article : Google Scholar
|
|
32.
|
Shirakata Y, Kimura R, Nanba D, Iwamoto R,
Tokumaru S, Morimoto C, Yokota K, Nakamura M, Sayama K, Mekada E,
et al: Heparin-binding EGF-like growth factor accelerates
keratinocyte migration and skin wound healing. J Cell Sci.
118:2363–2370. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Kannan-Thulasiraman P, Seachrist DD,
Mahabeleshwar GH, Jain MK and Noy N: Fatty acid-binding protein 5
and PPAR-β/δ are critical mediators of epidermal growth factor
receptor-induced carcinoma cell growth. J Biol Chem.
285:19106–19115. 2010.
|
|
34.
|
Uraguchi M, Morikawa M, Shirakawa M,
Sanada K and Imai K: Activation of WNT family expression and
signaling in squamous cell carcinomas of the oral cavity. J Dent
Res. 83:327–332. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Bielefeld KA, Amini-Nik S and Alman BA:
Cutaneous wound healing: recruiting developmental pathways for
regeneration. Cell Mol Life Sci. 70:2059–2081. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Collins CA and Watt FM: Dynamic regulation
of retinoic acid-binding proteins in developing, adult and
neoplastic skin reveals roles for beta-catenin and Notch
signalling. Dev Biol. 324:55–67. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Knoferle J, Ramljak S, Koch JC, Tonges L,
Asif AR, Michel U, Wouters FS, Heermann S, Krieglstein K, Zerr I,
et al: TGF-beta 1 enhances neurite outgrowth via regulation of
proteasome function and EFABP. Neurobiol Dis. 38:395–404. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Imai K, Hiramatsu A, Fukushima D,
Pierschbacher PD and Okada Y: Degradation of decorin by matrix
metalloproteinases: identification of the cleavage sites, kinetic
analyses and transforming growth factor-beta1 release. Biochem J.
322:809–814. 1997.PubMed/NCBI
|
|
39.
|
Chiba T, Maeda G, Kawashiri S, Kato K and
Imai K: Epigenetic loss of mucosa-associated lymphoid tissue 1
expression in patients with oral carcinomas. Cancer Res.
69:7216–7223. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Ohyama Y, Kawamoto Y, Chiba T, Maeda G,
Sakashita H and Imai K: Inhibition of TGF-β and EGF pathway gene
expression and migration of oral carcinoma cells by
mucosa-associated lymphoid tissue 1. Br J Cancer. 109:207–214.
2013.
|
|
41.
|
Tuncman G, Erbay E, Hom X, De Vivo I,
Campos H, Rimm EB and Hotamisligil GS: A genetic variant at the
fatty acid-binding protein aP2 locus reduces the risk for
hypertriglyceridemia, type 2 diabetes, and cardiovascular disease.
Proc Natl Acad Sci USA. 103:6970–6975. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Theocharis S, Klijanienko J, Giaginis C,
Rodriguez J, Jouffroy T, Girod A, Point D, Tsourouflis G and
Satre-Garau X: Peroxisome proliferator-activated receptor-γ in
mobile tongue squamous cell carcinoma: associations with
clinicopathological parameters and patients survival. J Cancer Res
Clin Oncol. 137:251–259. 2011.
|
|
43.
|
Yoshida K, Hirose Y, Tanaka T, Yamada Y,
Kuno T, Kohno H, Katayama H, Qiao Z, Sakata K, Sugie S, et al:
Inhibitory effects of troglitazone, a peroxisome
proliferator-activated receptor γ ligand, in rat tongue
carcinogenesis initiated with 4-nitroquinoline 1-oxide. Cancer Sci.
94:365–371. 2003.
|
|
44.
|
Kawamoto Y, Ohyama Y, Chiba T, Yagishita
H, Sakashita H and Imai K: Proteomic identification of keratin
alterations with enhanced proliferation of oral carcinoma cells by
loos of mucosa-associated lymphoid tissue 1 expression. Int J
Oncol. 43:729–736. 2013.
|
